Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | tar DNA-binding protein | 0.0135 | 0.7061 | 0.7061 |
Schistosoma mansoni | 6-phosphofructokinase | 0.0113 | 0.5774 | 0.5774 |
Loa Loa (eye worm) | RNA binding protein | 0.0135 | 0.7061 | 1 |
Brugia malayi | 6-phosphofructokinase | 0.0113 | 0.5774 | 0.8178 |
Trichomonas vaginalis | phosphofructokinase, putative | 0.0113 | 0.5774 | 1 |
Loa Loa (eye worm) | 6-phosphofructokinase | 0.0113 | 0.5774 | 0.8178 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.005 | 0.1984 | 0.281 |
Brugia malayi | MH2 domain containing protein | 0.0125 | 0.6438 | 0.9118 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.1984 | 0.1984 |
Treponema pallidum | diphosphate--fructose-6-phosphate 1-phosphotransferase | 0.0113 | 0.5774 | 1 |
Entamoeba histolytica | phosphofructokinase, putative | 0.0113 | 0.5774 | 1 |
Toxoplasma gondii | 6-phosphofructokinase | 0.0031 | 0.0845 | 0.5 |
Trichomonas vaginalis | phosphofructokinase, putative | 0.0113 | 0.5774 | 1 |
Plasmodium falciparum | ATP-dependent 6-phosphofructokinase | 0.0031 | 0.0845 | 0.5 |
Echinococcus multilocularis | geminin | 0.0184 | 1 | 1 |
Entamoeba histolytica | phosphofructokinase, putative | 0.0113 | 0.5774 | 1 |
Loa Loa (eye worm) | 6-phosphofructokinase | 0.0113 | 0.5774 | 0.8178 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.005 | 0.1984 | 0.281 |
Brugia malayi | phosphofructokinase | 0.0113 | 0.5774 | 0.8178 |
Schistosoma mansoni | tar DNA-binding protein | 0.0135 | 0.7061 | 0.7061 |
Schistosoma mansoni | hypothetical protein | 0.0184 | 1 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.005 | 0.1984 | 0.1984 |
Brugia malayi | TAR-binding protein | 0.0135 | 0.7061 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0184 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0036 | 0.1137 | 0.1137 |
Schistosoma mansoni | 6-phosphofructokinase | 0.0113 | 0.5774 | 0.5774 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0052 | 0.2117 | 0.2999 |
Echinococcus multilocularis | 6 phosphofructokinase | 0.0113 | 0.5774 | 0.5774 |
Schistosoma mansoni | tar DNA-binding protein | 0.0135 | 0.7061 | 0.7061 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0135 | 0.7061 | 1 |
Mycobacterium tuberculosis | Probable 6-phosphofructokinase PfkA (phosphohexokinase) (phosphofructokinase) | 0.0113 | 0.5774 | 0.5 |
Leishmania major | ATP-dependent phosphofructokinase | 0.0113 | 0.5774 | 0.5 |
Plasmodium vivax | 6-phosphofructokinase, putative | 0.0031 | 0.0845 | 0.5 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0135 | 0.7061 | 1 |
Mycobacterium ulcerans | 6-phosphofructokinase | 0.0113 | 0.5774 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.005 | 0.1984 | 0.1984 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0052 | 0.2117 | 0.2999 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.005 | 0.1984 | 0.1984 |
Plasmodium vivax | 6-phosphofructokinase, putative | 0.0031 | 0.0845 | 0.5 |
Brugia malayi | 6-phosphofructokinase | 0.0113 | 0.5774 | 0.8178 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.1984 | 0.1984 |
Echinococcus multilocularis | tar DNA binding protein | 0.0135 | 0.7061 | 0.7061 |
Entamoeba histolytica | phosphofructokinase, putative | 0.0113 | 0.5774 | 1 |
Toxoplasma gondii | phosphofructokinase PFKII | 0.0031 | 0.0845 | 0.5 |
Trichomonas vaginalis | phosphofructokinase, putative | 0.0113 | 0.5774 | 1 |
Brugia malayi | RNA binding protein | 0.0135 | 0.7061 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.1984 | 0.1984 |
Trypanosoma brucei | ATP-dependent 6-phosphofructokinase, glycosomal | 0.0113 | 0.5774 | 0.5 |
Chlamydia trachomatis | fructose-6-phosphate phosphotransferase | 0.0031 | 0.0845 | 0.5 |
Trypanosoma cruzi | ATP-dependent 6-phosphofructokinase, glycosomal | 0.0113 | 0.5774 | 0.5 |
Loa Loa (eye worm) | phosphofructokinase | 0.0113 | 0.5774 | 0.8178 |
Echinococcus granulosus | 6 phosphofructokinase | 0.0113 | 0.5774 | 0.5774 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.1137 | 0.1611 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0125 | 0.6438 | 0.9118 |
Loa Loa (eye worm) | TAR-binding protein | 0.0135 | 0.7061 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0135 | 0.7061 | 0.7061 |
Schistosoma mansoni | tar DNA-binding protein | 0.0135 | 0.7061 | 0.7061 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.005 | 0.1984 | 0.1984 |
Plasmodium falciparum | ATP-dependent 6-phosphofructokinase | 0.0031 | 0.0845 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.2117 | 0.2999 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0125 | 0.6438 | 0.9118 |
Trichomonas vaginalis | phosphofructokinase, putative | 0.0113 | 0.5774 | 1 |
Mycobacterium leprae | PROBABLE 6-PHOSPHOFRUCTOKINASE PFKA (PHOSPHOHEXOKINASE) (PHOSPHOFRUCTOKINASE) | 0.0113 | 0.5774 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0135 | 0.7061 | 0.7061 |
Giardia lamblia | Pyrophosphate-fructose 6-phosphate 1-phosphotransferase alpha subunit | 0.0031 | 0.0845 | 0.5 |
Toxoplasma gondii | phosphofructokinase domain-containing protein | 0.0031 | 0.0845 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0052 | 0.2117 | 0.2999 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0036 | 0.1137 | 0.1611 |
Chlamydia trachomatis | fructose-6-phosphate phosphotransferase | 0.0031 | 0.0845 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.